This study provides the first proof of the novel application of bismuth oxide as a radiosensitiser. It was shown that on the highly radioresistant 9L gliosarcoma cell line, bismuth oxide nanoparticles sensitise to both kilovoltage (kVp) or megavoltage (MV) X-rays radiation. 9L cells were exposed to a concentration of 50 μg.mL −1 of nanoparticle before irradiation at 125 kVp and 10 MV. Sensitisation enhancement ratios of 1.48 and 1.25 for 125 kVp and 10 MV were obtained in vitro, respectively. The radiation enhancement of the nanoparticles is postulated to be a combination of the high Z nature of the bismuth (Z = 83), and the surface chemistry. Monte Carlo simulations were performed to elucidate the physical interactions between the incident radiation and the nanoparticle. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 
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Introduction
External X-ray Radiation Therapy is a common treatment for many cancers, which has been used extensively for many years. Despite the improvement of this cancer modality [1, 2] , there are still unwanted side effects which need to be addressed [3] .
One possible solution to improve the efficacy of X-ray radiotherapy exists in the use of metal nanoparticles (NPs) as individual radiosensitising agents. Investigations into gold NPs [4] [5] [6] [7] and Platinum [8, 9] NPs were performed to quantify the biocompatibility of the proposed nanomaterials.
The metallic NPs were shown to be radioenhancing under kilovolt (kVp) and megavolt (MV) radiation fields, however, they presented two problems. First, there was no guarantee that these nanomaterials would be biocompatible on the nanoscale. Studies into pure metal NPs showed that the size and morphology of the nanoparticle often resulted in varying degrees of toxicity [10, 11] . Metal NPs with diameters below 5 nm can freely diffuse into the nucleus and interact directly to DNA, resulting in necrosis [9, 10] . Second, the metals used for radiosensitisation require a high atomic number (high Z), and are also heavy metals. It was shown that these NPs induced toxicity as the treatment concentrations increased.
To solve these two issues, high Z nanoceramics, such as the promising tantalum pentoxide Ta 2 O 5 [12] , have started to be investigated. The Ta 2 O 5 nanoparticle aggregates demonstrated the required radiosensitisation provided by the heavy Ta metal, and also the necessary biocompatibility thanks to the oxide form.
Bismuth is a better candidate for high Z radiosensitiser research since it is one of the heaviest naturally occurring elements of the periodic table [13] . Bismuth oxide and other bismuth-based compounds are also known to be biocompatible [14] . They have been extensively used in many medical and cosmetic applications for many years [15] . In addition, Stewart et al [16] showed that bismuth oxide nanoparticles could be tailored with different oxygen contents, inducing cell proliferation or toxicity. Another paper by Bogusz et al [17] highlighted that a theranostic system based on bismuth oxide nanoparticles would be highly effective in the treatment of cancer. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   4 This research is aimed to investigate the novel application of high Z bismuth oxide nanoparticles as radiosensitisers for cancer therapy. The bismuth oxide nanoparticles were synthesised and irradiated with clinical 125 kVp and 10 MV X-ray beams. The cell clonogenic and internalisation assays were then performed. Monte Carlo simulations performed complemented the experimental work providing insight into the physical mechanisms behind dose enhancement and the effect of the particle morphology on these physical mechanisms.
Methods and Materials

Experimental
Synthesis
The bismuth based compounds were fabricated at the Institute of Superconducting and Electronic Materials (ISEM). The biocompatible Bi 2 O 3 nanoparticles were synthesised via the precipitation route [16, 18] . Bismuth Nitrate (99.9 %, Sigma-Aldrich, Australia) was dissolved in 70% Nitric acid (50-70% Merck, Australia), and then 30% Ammonium Hydroxide (Sigma Aldrich, Australia) was added in small increments until a white precipitate appeared. This was extracted using a centrifuge and washed with deionised (DI) water. The precipitate was transferred to a beaker of DI water and stirred continuously for 5.5 hours at 100˚C. The precursor was extracted and washed as before then annealed under argon for 4 hours in a tube furnace at 530˚C.
X-ray diffraction (XRD)
The Bi 2 O 3 was examined using an Enhanced Mini-Materials Analyser (EMMA) X-Ray Diffractometer at 40 kV and 25 mA. The X-ray diffractometer scanned between 20˚ and 80˚ at a step rate of 2.00˚min -1 and step size of 0.02˚. The mean crystalline size was determined using the Scherrer equation, while the material phase was extracted from the ICDD database using the Traces software [19, 20] . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 5
Surface area
The surface area of the nanoparticles was examined using the methylene blue test due to negative effects induced by the drying process of Brunauer Emmet Teller (BET) gas adsorption surface area method. Bismuth oxide (100 mg) was dispersed in 50 mL deionised (DI) water and 12 mg of Methylene Blue (MB) added. After stirring and leaving overnight, a sample was taken from the stock and diluted accordingly for UV-vis analysis. The absorption at 665 nm of the MB solution was measured using a Shimatzu 3600 NIR UV-vis Spectrophotometer (Shimadzu, Kyoto, Japan). After examination, 4 mg of MB was added to the stock with 5 mL of DI. This was repeated for three days until the ideal concentration was determined. 10 000 events were recorded. The degree of internalisation of the nanomaterials was determined with FACSDiva software, assessing both forward and side scatter intensities [17, 22] .
Media preparation
The 9L gliosarcoma cells were maintained in a T75cm 2 flask with completed Dulbecco's
Modified Eagle Medium (c-DMEM) (DMEM from GIBCO, supplemented with 10% Fetal Bovine Serum (FBS) and 1% Penicillin and Streptomycin) and incubated at 37 ˚C with 5% (v/v) CO 2 [12] .
Determination of Bi 2 O 3 k-edge and optimum kVp radiation
To optimise the dose enhancement effects of the bismuth oxide the correct filter and beam energy needed to be calculated. This optimal energy was the closest to the maximum photon mass absorption energy for the bismuth oxide compared to water, maximising the secondary photoelectric particle production. Using the Xmudatv1.0.1 program the photo attenuation coefficients for water and bismuth oxide were generated based on total mass energy absorption. The ratio between the two curves was graphed as a function of energy [12] .
Irradiation with kVp and MV beams
All irradiation experiments were carried out at the radiation oncology department of the Prince of were taken into account. The flasks were then irradiated with the source perpendicular (z-axis) to the flasks. Irradiated flasks of the same dosage were irradiated together to reduce individual dose variation. Non-irradiated control samples, with and without bismuth oxide NPs, were handled under the same conditions as the irradiated samples [12] . The experiments were performed in triplicate with multiple repetitions.
Clonogenic cell survival assay
Clonogenic assay was used as the radiobiological endpoint to assess the effects of 50 g.mL
concentration of bismuth oxide NPs on cell survival, compared to control (no NPs). After irradiation, cells were sub-cultured at low density into 100 mm diameter Petri dishes (Sigma) with 10 mL c-DMEM and incubated for 15 doubling times. Following this, each dish was washed with 5 mL PBS (with calcium and magnesium ions) and fixed and stained with 5 mL of a (25% crystal violet, 75% ethanol) solution. Colonies consisting of no less than 50 cells were counted (n) and compared with initial seeding values (I) to obtain the plating efficiency (PE) [12, 16] , expressed as:
For each group, the surviving fraction (SF) is determined as the ratio of the PE of the irradiated sample (PE x ) by PE of the non-irradiated control (PE c ): ) and β (Gy -2 ), are indicative of cell radiosensitivity and repair effectiveness, respectively [7] . They are derived from the LQM equation (4): (4) We quantified the degree of dose enhancement introduced by the NPs by means of the Sensitisation Enhancement Ratio (SER), defined as the ratio of doses giving 10% cell surviving fraction. SER represents a radioenhancement based on the radiobiological endpoint from the LQM curves, and is dependent upon the delivered dose [5] .
Monte Carlo Simulation
Simulations were performed using Geant4 (version 9.6 patch 2), a Monte Carlo code modelling particle transport through matter [23] , at the Centre for Medical and Radiation Physics (CMRP). The simulation set-up was modelled to retain the essential characteristics of the experimental configuration necessary to investigate the physical mechanisms behind the results of the cell experiments and to investigate the effect of the shape of the NP aggregate on the energy deposition enhancement.
The geometry consisted of a cell population modelled as an array of spherical water cell volumes with 10 µm diameter (shown in Figure 1 ), placed in a water phantom at a depth of 6 mm and 25 mm for kVp and MV beams, respectively, to obtain electronic equilibrium. The dimensions of the phantom reflect the sizes of the real phantom used in the experiments. Geant4 Low Energy electromagnetic physics was used with Penelope models to describe the interactions of particles down to 100 eV in the cell population. Atomic deexcitation processes (including both fluorescence and Auger electron emission) were activated in the simulation. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 9
The NP aggregate was modelled as a sphere of 10 µm diameter, a cube with 10 µm sides or a plate with dimensions 10 µm x 10 µm x 1 µm, placed at the centre of the cell populations, as shown in
The energy spectra of 125 kVp and 10 MV X-ray beams were simulated using SpekCalc v 1.1 [24] and provided by ARPANSA [25] , respectively. A 100 µm x 100 µm beam of photons was incident normally on the phantom edge, along the Z axis (see Figure 2) . A total of 6 x 10 6 and 3.5 x 10 6 primary photons were incident on the phantom in order to achieve sufficient statistical results in the kVp and MV beam simulations, respectively.
The energy deposited in each cell was calculated with and without the NP. In this study, the dose The DEF was calculated for the different shapes of the NP nanomaterial under study. This factor depends on the mass and shape of the NP aggregate. In order to isolate the effect of the increasing mass of the NP aggregates, the DEF was scaled with respect to the NP aggregate mass. The scaled DEF, referred to as DEF S , was calculated as DEF/m NP where m NP is the mass of the NP aggregate placed in the cell population. In order to evaluate the effect of the NP aggregate shape (in terms of increasing surface area to volume ratio), the DEF and DEF S were compared.
The spectra and the Linear Energy Transfer (LET) of secondary electrons produced by the incident X-ray beam were calculated. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 10
Results
Experimentation
X-ray Diffraction
The bismuth oxide nanoparticles were characterised as alpha phase [26] by the XRD spectrum.
The Scherrer equation was applied to the three peaks (1 2 0), (2 0 0), and (-2 2 1) which showed the Bi 2 O 3 nanoparticles had a size range of range of 50 -70nm. This can be observed in Figure 3 , denoted by the transparency of the platelets.
Surface area
The optimal MB concentration for the 100 mg of bismuth oxide nanoparticles was determined to be 0.26 ± 0.02 mg.mL -1 . Using the cation replacement point, the surface area of the NPs was determined to be 48.7 ± 4.5 cm 2 .g -1 . There is currently no literature value for comparison. Correct sonication played a crucial role in this process due to the tendency of the nanoparticles to aggregate.
Cell internalisation
The comparison of side scatter (SSC) v.s. forward scatter (FSC) light values at 24 hours showed a dramatic increase in the side scatter of the NPs samples over the control. The SSC is proportional to the cell granularity and can be used to examine the cellular uptake of the nanoparticles [27] . The relative increase in scatter is 7 times higher than the controls indicating that a large quantity of nanoparticles had been taken into the cells, as denoted by the dramatic change in scatter distribution (Figure 4 ).
kVp energy determination
The maximum differential absorption energy is around 40 keV with the K-edge being located at 91 keV ( Figure 5) . These values were then examined against the available spectra for the kVp orthovoltage unit at Prince of Wales Hospital and it was determined that filter 4 would be the most 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 11
Intrinsic toxicity, survival curves, and radiosensitivity parameters
The Bi 2 O 3 NP used in this experiment underwent argon annealing and were found to have no cytotoxicity on 9L cells as previously described [16] . The first radiation energy examined was 125 kVp, which corresponds to the calculated optimum energy of Bi 2 O 3 (see Figure 5) , and is used for treatment of superficial cancers. The extracted α and β parameters from the linear quadratic curves were 0.075 ± 0. that the material is a highly effective radiosensitiser ( Figure 6 ).
The effect of bismuth oxide nanoparticles was also examined with 10 MV radiation to investigate how effective it would be for treating deeper seeded cancers, like brain cancer ( Figure 7 ).
The extracted α and β parameters from the linear quadratic curves were 0.150 ± 0. 
Results of the simulation study
Effect of NP aggregate geometry in dose enhancement
The physical dose enhancement produced by the Bi 2 O 3 sphere, cube, and plate placed in the cell population was calculated in terms of DEF and DEF S as explained in the Methodology section. Figure   8 shows the DEF and DEF S in cells with respect to radial distance from NP centre in cell layer 3, downstream of the NP, and cell layer 2, containing the NP, in the 125 kVp X-ray field. 
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(both equal to 0.6 x 10 6 ). Since the in vitro conditions assume a monolayer of cells at the time of irradiation, the cells in the bottom layer (layer 3 in Figure 1 ) below the NP aggregate are also shown in Table 1 .
Secondary electron spectra
The kinetic energy and LET spectra of secondary electrons entering all the cells in the population were analysed to assess the change in the quality of the secondary electrons due to the presence of each NP aggregate shape. The results are shown for the kVp and MV beam in Figure 9 where the spectra are shown per incident photon on the water phantom. It can be observed that the secondary electron spectra and LET are not significantly enhanced by the Bi 2 O 3 NP in the 10 MV photon field. This is in contrast to the kilovoltage case where there is a clear enhancement of the secondary electron production. In particular, the greatest increase in number of secondary electrons is observed in the case of the cube geometry, followed by the sphere and plate.
These secondary electron spectra results agree with the DEF reported in Table 1 for the 125 kVp and 10 MV photon fields, respectively. The enhancement of secondary electron production is dependent on the geometry with the cube geometry providing the highest number of secondary electrons due to the absolute increase in the mass of Bi 2 O 3 NP material placed in the cell population.
When the DEF s is calculated, it is observed that the plate geometry is the most efficient enhancer. This is due to the increased chance of secondary electrons to be absorbed within the NP aggregate itself with increasing geometrical size and lower surface area to volume ratio. The plate geometry allows more electrons to escape the surface, as the thickness of the plate is only 1 µm, and the range of which is less than the range in Bi 2 O 3 of a 12 keV electron [28] , meaning most of the electrons will be able to escape the NP geometry. By contrast, the range of a 50 keV electron in Bi 2 O 3 is 10.6 µm which means that electrons originate in the cube with energy lower than this value will have a reduced probability of escaping. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 13
Discussion
The MB surface area method provided two advantages over the BET. The first was that the suspension was a closer match for the liquid cell environment, closer simulating the actual particle size found during testing. The second was that in suspension, the full surface area could be measured as the nanoplatelets aggregate when dried and lose access to the majority of their surface area.
Cell internalisation measurement showed that the nanoparticles were highly internalised after 24 hours (Figure 4 ). However, due to the physical parameters of the nanoparticles, the Bi 2 O 3 NPs should not penetrate the nucleus and interfere with the DNA resulting in NP induced apoptosis, as is the case of nanoparticles with diameters smaller than 5 nm [10] .
Both Geant4 simulations and in vitro experiments were essential for this study. The simulations provided insight into the physical processes behind physical dose enhancement in the cells, whereas in vitro measurements allowed the study of the synergy among physical, chemical, and biological mechanisms when enhancing radiotherapy treatment by means of nanoparticles.
The Geant4 simulations demonstrated that in the kVp X-ray field, Bi 2 O 3 had considerable physical dose enhancement properties, with a dependence on the NP aggregate geometrical shape, related to Surface Area to Volume ratio (SA/V). The dose enhancement was shown to be significant (DEF around 2-3 in the cell population studied, depending on the geometry of the nanoparticle aggregate) in the 125 kVp photon field compared to no significant dose enhancement calculated in the 10 MV field. This is due to the strong increase in photoelectric effect cross-section in the kVp energy range for high Z materials, whereas, electron pair production dominates at 10 MV with contributions from Compton scattering. This effect is caused by the strong Z-dependence (approximately power 3-4) of the photoelectric effect compared to pair production (above 1.022 MeV), which has mass attenuation coefficient approximately proportional to Z, and Compton scattering, which is not strongly Z-dependent [29] . This means that the higher energy photons in the 10 MV spectra are unlikely to strongly contribute to radiation dose enhancement. The megavoltage simulation study found no significant enhancement for any NP morphologies studied. The simulation results for Bi 2 O 3 under a kilovoltage beam are in agreement with the experimental data published by Alqathami et al [30] . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 14
The cell survival curves (Figures 6 and 7) showed that the bismuth oxide has an SER of 1.48 and 1.25 in kVp and MV beam, respectively. The highest SER values for Au NPs is an enhancement of 1.41 obtained at 150 kVp on a less radioresistant cell line. The SER reduced when the Au NPs were examined in more resistant cells [5] . Tantalum oxide has shown an SER of 1.33 on 9L cells at 10MV [12] . The DEF observed in the simulated cell population was 1.87 ± 0.01 in the layer of cells below the Bi 2 O 3 NP plate in the 125 kVp X-ray field. This is a DEF calculated in a small number of cells close to the NP aggregate in this simulation and cannot be compared directly to the experimental SERs observed. However, the High-Z dose enhancement properties of Bi 2 O 3 NPs are an important factor influencing increased SER and the calculated DEF from the Monte Carlo simulation reflects this.
The effectiveness of any nanoparticle system in radiation fields is due to a number of factors including cell line, radiation energy, particle morphology, subcellular localisation, and concentration.
The 9L gliosarcoma cells used in this study are known to be more radio-resistant and more hypoxic than most of other cancerous cells. Oxygen levels in cells have been shown to alter the effectiveness of radiation therapy, as oxygen is responsible for indirect damage through radiation induced radicals [31] . Therefore, observations on 9L cells should be amplified on less radio-resistant and hypoxic cells.
The surface chemistry of the nanoparticles also has an important effect on the effectiveness of the radiosensitiser as indirect damage is the major mechanism behind cancer apoptosis in radiation therapy [32] . It has been shown that nanoparticles can demonstrate catalytic behavior under radiation fields becoming radiocatalysts. In the case of our NPs, it is hypothesized that the energy of the photons excite the NPs, causing them to act as radiocatalysts and split water molecules into HO˙ and H˙ radicals [33] . This produces additional ROS which increases the effectiveness of the radiosensitiser and would not be predicted in simulations.
The morphology (SA/V) of the radiosensitising NPs also plays an important role in their effectiveness. The Monte Carlo simulations were designed to model the experimental set up, as stated in section 2.2, with the incident x-ray beam along the Z-axis. Each 10μm diameter cell within the array was measured and the average DEF taken for the entire population. Comparatively, the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 The apparent disparity between the Monte Carlo simulations and the in vitro survival curves can be explained through a comparison of the analysis techniques [34] . DEF calculations are the physical ratio of energy deposited with a NP aggregate compared to a pure water phantom. This produces DEF values which are independent of therapeutic dose for a given X-ray energy, i.e. 125 kVp or 10 MV.
Alternatively, the SER is a radiobiological endpoint based on a quadratic exponential equation (eqn 4), with the radioenhancement being dependent upon the dose for a given X-ray energy, as seen in Figures 6 and 7 , and does not scale linearly.
The Local Effect Model (LEM) for radiation enhancement assists in describing the NP-radiation interactions in the biological context. It states that the dose enhancement of a single particle is effective only to a small subvolume of the total, i.e. the cytoplasm of a cell with an internalised NP.
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Conclusion:
